Atara Biotherapeutics Statistics
Total Valuation
ATRA has a market cap or net worth of $96.56 million. The enterprise value is $96.57 million.
| Market Cap | 96.56M |
| Enterprise Value | 96.57M |
Important Dates
The last earnings date was Wednesday, August 12, 2026, after market close.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ATRA has 10.04 million shares outstanding. The number of shares has increased by 36.26% in one year.
| Current Share Class | 10.04M |
| Shares Outstanding | 10.04M |
| Shares Change (YoY) | +36.26% |
| Shares Change (QoQ) | +6.76% |
| Owned by Insiders (%) | 3.68% |
| Owned by Institutions (%) | 21.72% |
| Float | 4.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 33.65 |
| PS Ratio | 16.38 |
| Forward PS | 3.00 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 16.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.98
| Current Ratio | 1.98 |
| Quick Ratio | 1.49 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.96 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -24.14% |
| Return on Invested Capital (ROIC) | -78.42% |
| Return on Capital Employed (ROCE) | -78.90% |
| Weighted Average Cost of Capital (WACC) | 6.44% |
| Revenue Per Employee | $619,400 |
| Profits Per Employee | -$1.67M |
| Employee Count | 10 |
| Asset Turnover | 0.21 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ATRA has paid $29,000 in taxes.
| Income Tax | 29,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.33% in the last 52 weeks. The beta is 0.11, so ATRA's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | -15.33% |
| 50-Day Moving Average | 8.93 |
| 200-Day Moving Average | 8.67 |
| Relative Strength Index (RSI) | 59.19 |
| Average Volume (20 Days) | 50,567 |
Short Selling Information
The latest short interest is 427,435, so 4.26% of the outstanding shares have been sold short.
| Short Interest | 427,435 |
| Short Previous Month | 477,268 |
| Short % of Shares Out | 4.26% |
| Short % of Float | 9.25% |
| Short Ratio (days to cover) | 9.36 |
Income Statement
In the last 12 months, ATRA had revenue of $6.19 million and -$16.69 million in losses. Loss per share was -$1.19.
| Revenue | 6.19M |
| Gross Profit | 4.66M |
| Operating Income | -11.19M |
| Pretax Income | -16.66M |
| Net Income | -16.69M |
| EBITDA | -11.06M |
| EBIT | -11.19M |
| Loss Per Share | -$1.19 |
Balance Sheet
The company has $9.87 million in cash and $9.88 million in debt, with a net cash position of -$6,000 or -$0.00 per share.
| Cash & Cash Equivalents | 9.87M |
| Total Debt | 9.88M |
| Net Cash | -6,000 |
| Net Cash Per Share | -$0.00 |
| Equity (Book Value) | -37.00M |
| Book Value Per Share | -3.92 |
| Working Capital | 6.68M |
Cash Flow
| Operating Cash Flow | -21.90M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 128,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -21.90M |
| FCF Per Share | -$2.18 |
Margins
Gross margin is 75.27%, with operating and profit margins of -180.59% and -269.42%.
| Gross Margin | 75.27% |
| Operating Margin | -180.59% |
| Pretax Margin | -268.95% |
| Profit Margin | -269.42% |
| EBITDA Margin | -178.53% |
| EBIT Margin | -180.59% |
| FCF Margin | n/a |
Dividends & Yields
ATRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -36.26% |
| Shareholder Yield | -36.26% |
| Earnings Yield | -16.44% |
| FCF Yield | -21.58% |
Analyst Forecast
The average price target for ATRA is $13.67, which is 42.10% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.67 |
| Price Target Difference | 42.10% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | -42.76% |
| EPS Growth Forecast (3Y) | -41.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 20, 2024. It was a reverse split with a ratio of 1:25.
| Last Split Date | Jun 20, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
ATRA has an Altman Z-Score of -135.53 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -135.53 |
| Piotroski F-Score | 2 |